CompletedNot applicableNCT03445052
XPAND Trial: Enhancing XP Photoprotection Activities - New Directions
Studying Xeroderma pigmentosum
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Principal Investigator
- Robert Sarkany, FRCP MD CCSTGuy's and St Thomas' NHS Foundation Trust
- Intervention
- XPAND(behavioral)
- Enrollment
- 15 enrolled
- Eligibility
- 16 years · All sexes
- Timeline
- 2018 – 2020
Study locations (1)
- Guy's St Thomas' NHS Foundation Trust, London, United Kingdom
Collaborators
King's College London · Newcastle University · University of Cambridge
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03445052 on ClinicalTrials.gov